Estonia -
Kiestonia -
Ravimiamet
nodexon tablett
norameda uab - deksametasoon - tablett - 4mg 30tk; 4mg 100tk; 4mg 20tk
Estonia -
Kiestonia -
Ravimiamet
dexamethason krka tablett
lex ano uab - deksametasoon - tablett - 4mg 20tk
Estonia -
Kiestonia -
Ravimiamet
dexamethason krka tablett
ideal trade links uab - deksametasoon - tablett - 4mg 28tk; 4mg 56tk; 4mg 100tk
Estonia -
Kiestonia -
Ravimiamet
dexamethason krka tablett
ideal trade links uab - deksametasoon - tablett - 20mg 10tk; 20mg 50tk; 20mg 30tk; 20mg 20tk
Umoja wa Ulaya -
Kiestonia -
EMA (European Medicines Agency)
lytgobi
taiho pharma netherlands b.v. - futibatinib - cholangiocarcinoma - antineoplastilised ained - lytgobi monotherapy is indicated for the treatment of adult patients with locally advanced or metastatic cholangiocarcinoma with a fibroblast growth factor receptor 2 (fgfr2) fusion or rearrangement that have progressed after at least one prior line of systemic therapy.